India to Poland: Daunorubicin Export Trade Route

The India to Poland Daunorubicin corridor is one of India's established pharmaceutical export routes, with 20 shipments documented worth a combined $23.8K USD. The route is dominated by SARA INTERNATIONAL, which alone accounts for roughly 36% of all export value, reflecting the consolidated nature of India's daunorubicin manufacturing sector.

Across 6 active suppliers, the average shipment value stands at $1.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 70% of all shipments, consistent with daunorubicin's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 32 days port-to-port. The route has recorded an annual growth rate of 32.4%, placing it at rank #11 among India's top daunorubicin export destinations globally.

On the import side, key buyers of Indian daunorubicin in Poland include TO THE CONSIGNEE-, CONCERN PERSON SALUS INTERNATIONAL SP ZO O UL PULASKIEGO, CONSIGNEE- BIALMED SP ZOO UL KAZIMIERZOWSKA and 9 others. TO THE CONSIGNEE- is the single largest importer with 2 shipments valued at $6.0K USD.

India's daunorubicin exports to Poland are driven primarily by a handful of large-scale manufacturers. SARA INTERNATIONAL with 9 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 6 active exporters signals a competitive but concentrated market — buyers in Poland benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — SARA INTERNATIONAL, ZYPHAR'S PHARMACEUTICS PRIVATE LIMITED, VAMA LIFECARE PRIVATE LIMITED — together account for 83% of total trade value on this route. The average shipment value of $1.2K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as asper document no: zppl/xp/2324/117 date:13/09/2023 sr no. 1 daunorubicin injection i.p. 20 mg and pharmaceutical product for human use daunorubicin 20 mg vial each vial containsdaunoruicin hcl equivalent to daunorubi, suggesting that buyers in Poland tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, TO THE CONSIGNEE- is the largest importer with 2 shipments worth $6.0K USD — representing 25% of all daunorubicin imports from India on this route. A total of 12 buyers are active on this corridor.